ArticleJournal of translational medicine2025

The TP53-LGALS4 axis modulates the tumor immune microenvironment and synergizes with anti PD-L1 therapy in colorectal cancer.

Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.